Inventor · disambiguated record
Laurent Galibert
Also filed as: GALIBERT LAURENT · GALIBERT LAURENT J
13 granted patents·7 pending applications·397 citations·filing 1998–2022
93Inventor score
Top patents by PatentIndex Score
20 records- 0196US6537763B2Receptor activator of NF-κBIMMUNEX CORP·Filed 2001·Granted Mar 25, 2003·64 cites·12 claims
- 0295US6479635B1Receptor activator of NF-κBIMMUNEX CORP·Filed 2000·Granted Nov 12, 2002·55 cites·24 claims
- 0394US7267960B2Antagonists and agonists of LDCAM and methods of useAMGEN INC·Filed 2004·Granted Sep 11, 2007·42 cites·12 claims
- 0494US6838262B1Isolated DNA molecule encoding rank ligandIMMUNEX CORP·Filed 2000·Granted Jan 4, 2005·30 cites·34 claims
- 0593US6528482B1Receptor activator of NF-κBIMMUNEX CORP·Filed 1999·Granted Mar 4, 2003·62 cites·10 claims
- 0692US6271349B1Receptor activator of NF-κBIMMUNEX CORP·Filed 1998·Granted Aug 7, 2001·132 cites·4 claims
- 0777US8569456B2Receptor activator of NF-kappaBANDERSON DIRK M·Filed 2012·Granted Oct 29, 2013·1 cites·4 claims
- 0877US8333963B2Method of inhibiting osteoclast activityANDERSON DIRK M·Filed 2010·Granted Dec 18, 2012·1 cites·7 claims
- 0970US7186818B2DNA encoding soluble variants of human OX2 receptorsIMMUNEX CORP·Filed 2002·Granted Mar 6, 2007·8 cites·8 claims
- 1069US7589175B2Human OX2 receptorsIMMUNEX CORP·Filed 2007·Granted Sep 15, 2009·2 cites·3 claims
- 1162US7790684B2Method of inhibiting osteoclast activityIMMUNEX CORP·Filed 2008·Granted Sep 7, 2010·0 cites·10 claims
- 1261US8043615B2Methods of antagonizing LDCAM and CRTAMAMGEN INC·Filed 2007·Granted Oct 25, 2011·0 cites·6 claims
- 1359US7956163B2Antibodies that bind human OX2 receptorsIMMUNEX CORP·Filed 2009·Granted Jun 7, 2011·0 cites·6 claims
- 1455US2014178376A1Method of inhibiting osteoclast activityIMMUNEX CORP·Filed 2013·Application pending·0 cites
- 1554US2005089522A1Methods of inhibiting osteoclastogenesisIMMUNEX CORP·Filed 2004·Application pending·0 cites
- 1653US2013101585A1Method of inhibiting osteoclast activityIMMUNEX CORP·Filed 2012·Application pending·0 cites
- 1752US2024376149A1Novel Modulators of GABABR1aVIB VZW·Filed 2022·Application pending·0 cites
- 1845US2013052663A1Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane ReceptorsDE SMEDT THIBAUT·Filed 2011·Application pending·0 cites
- 1945US2013079246A1Methods and Tools for Screening Agents Exhibiting an Activity on Receptors of the Tumor Necrosis Factor Receptor SuperfamilyDE SMEDT THIBAUT·Filed 2011·Application pending·0 cites
- 2044US2004071657A1Chemoattractant recruitment of dendritic cells for enhancement of immunizationFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurent Galibert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →